Cyclomethycaine hydrochloride,
Topocaine hydrochloride,
Surfacaine hydrochloride,
Surfathesin hydrochloride,
p-Cyclohexyloxybenzoic acid 3-(2-methylpiperidino)propyl ester hydrochloride,
3-(2-Methylpiperidino)propyl p-(cyclo-hexyloxy)benzoate hydrochloride,
1-Piperidinepropanol, 2-methyl-, p-(cyclohexyloxy)benzoate, hydrochloride,
N-(3-Hydroxypropyl)pipecoline hydrochloride p-cyclohexyloxybenzoic acid ester,
537-61-1,
Benzoic acid, p-(cyclohexyloxy)-, 3-(2-methylpiperidino)propyl ester, hydrochloride,
Cyclomethycaine HCl,
AC1Q3EEL,
C22H33NO3.HCl,
SCHEMBL634210,
Cyclomethycaine (hydrochloride),
AC1L1W25,
LS-36691,
3-(2-methylpiperidin-1-yl)propyl 4-(cyclohexyloxy)benzoate hydrochloride,
3-(2-methylpiperidin-1-yl)propyl 4-cyclohexyloxybenzoate hydrochloride,
3-(2-methylpiperidin-1-yl)propyl 4-cyclohexyloxybenzoate,hydrochloride,
3-(2-methylpiperidin-1-yl)propyl 4-(cyclohexyloxy)benzoate hydrochloride(1:1),
UNII-2FYK6V755H,
C22H33NO3.ClH,
2FYK6V755H,
C22-H33-N-O3.Cl-H,
CID10838,